{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:13:01Z","timestamp":1771485181463,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"29","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.vaccine.2020.04.001","type":"journal-article","created":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T01:31:11Z","timestamp":1590024671000},"page":"4632-4639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Infant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: An open-label, parallel, randomised controlled trial"],"prefix":"10.1016","volume":"38","author":[{"given":"Daan","family":"Barug","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guy A.M.","family":"Berbers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies A.","family":"van Houten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjan","family":"Kuijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Pronk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth A.M.","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nynke Y.","family":"Rots","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.001_b0005","unstructured":"European Centre for Disease Prevention and Control. Vaccine Schedule. Available at: http:\/\/vaccine-schedule.ecdc.europa.eu\/Pages\/Scheduler.aspx."},{"issue":"suppl 4","key":"10.1016\/j.vaccine.2020.04.001_b0010","doi-asserted-by":"crossref","first-page":"S236","DOI":"10.1093\/cid\/ciw559","article-title":"Sustained effectiveness of the maternal pertussis immunization program in England 3 years following introduction","volume":"63","author":"Amirthalingam","year":"2016","journal-title":"Clin Infect Diseases: An Off Publ Infect Diseases Soc Am"},{"issue":"6","key":"10.1016\/j.vaccine.2020.04.001_b0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/INF.0b013e318288b610","article-title":"The protective role of maternally derived antibodies against Bordetella pertussis in young infants","volume":"32","author":"Heininger","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"10.1016\/j.vaccine.2020.04.001_b0020","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1473-3099(07)70113-5","article-title":"The case for maternal vaccination against pertussis","volume":"7","author":"Mooi","year":"2007","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.001_b0025","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.vaccine.2015.10.100","article-title":"Pertussis vaccination during pregnancy in Belgium: results of a prospective controlled cohort study","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2020.04.001_b0030","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/cid\/ciy244","article-title":"A randomized controlled trial of the safety and immunogenicity of tetanus, diphtheria, and acellular pertussis vaccine immunization during pregnancy and subsequent infant immune response","volume":"67","author":"Halperin","year":"2018","journal-title":"Clin Infect Diseases: An Off Publ Infect Diseases Soc Am"},{"issue":"17","key":"10.1016\/j.vaccine.2020.04.001_b0035","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1001\/jama.2014.3633","article-title":"Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial","volume":"311","author":"Munoz","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.vaccine.2020.04.001_b0040","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S1473-3099(18)30717-5","article-title":"Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial","volume":"19","author":"Barug","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.04.001_b0045","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/S1473-3099(17)30229-3","article-title":"Maternal immunisation: collaborating with mother nature","volume":"17","author":"Marchant","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.04.001_b0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.vaccine.2015.10.098","article-title":"Pertussis vaccination during pregnancy in Vietnam: results of a randomized controlled trial Pertussis vaccination during pregnancy","volume":"34","author":"Hoang","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2020.04.001_b0055","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/cid\/civ695","article-title":"Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator","volume":"61","author":"Ladhani","year":"2015","journal-title":"Clin Infect Diseases: An Off Publ Infect Dis Soc Am"},{"issue":"12","key":"10.1016\/j.vaccine.2020.04.001_b0060","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1097\/INF.0000000000001601","article-title":"Pneumococcal immune response in infants whose mothers received tetanus, diphtheria and acellular pertussis vaccination during pregnancy","volume":"36","author":"Maertens","year":"2017","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2020.04.001_b0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.eclinm.2019.06.010","article-title":"The effect of maternal immunisation during pregnancy on infant vaccine responses","volume":"13","author":"Zimmermann","year":"2019","journal-title":"EClinicalMedicine."},{"issue":"11","key":"10.1016\/j.vaccine.2020.04.001_b0070","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1586\/erv.11.142","article-title":"Glycoconjugate vaccines and immune interactions, and implications for vaccination schedules AU - Borrow Ray","volume":"10","author":"Dagan","year":"2011","journal-title":"Exp Rev Vacc"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2020.04.001_b0075","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jim.2008.02.018","article-title":"Development and validation of a multiplex immunoassay for the simultaneous determination of serum antibodies to Bordetella pertussis, diphtheria and tetanus","volume":"335","author":"van Gageldonk","year":"2008","journal-title":"J Immunol Methods"},{"issue":"3","key":"10.1016\/j.vaccine.2020.04.001_b0080","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1128\/CVI.00364-08","article-title":"Simultaneous detection of Haemophilus influenzae type b polysaccharide-specific antibodies and Neisseria meningitidis serogroup A, C, Y, and W-135 polysaccharide-specific antibodies in a fluorescent-bead-based multiplex immunoassay","volume":"16","author":"de Voer","year":"2009","journal-title":"Clin Vacc Immunol: CVI"},{"issue":"4","key":"10.1016\/j.vaccine.2020.04.001_b0085","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1128\/CVI.00408-09","article-title":"Optimization and application of a multiplex bead-based assay to quantify serotype-specific IgG against Streptococcus pneumoniae polysaccharides: response to the booster vaccine after immunization with the pneumococcal 7-valent conjugate vaccine","volume":"17","author":"Elberse","year":"2010","journal-title":"Clin Vacc Immunol: CVI"},{"key":"10.1016\/j.vaccine.2020.04.001_b0090","unstructured":"World Health Organization (2009). Immunological basis for immunization : module 2: diphtheria - update 2009. World Health Organization. https:\/\/apps.who.int\/iris\/handle\/10665\/44094."},{"key":"10.1016\/j.vaccine.2020.04.001_b0095","unstructured":"World Health Organization. (2018). Immunological basis for immunization series: module 3: tetanus-update 2018. (Immunological basis for immunization series; module 3). https:\/\/www.who.int\/immunization\/documents\/ISBN9789241513616\/en\/."},{"key":"10.1016\/j.vaccine.2020.04.001_b0100","unstructured":"Recommendations for the production and control of pneumococcal conjugate vaccines. In: WHO Expert Committee on Biological Standardization. Fifty-fourth report. Geneva, World Health Organization, 2005 (WHO Technical Report Series, No. 927), Annex 2. http:\/\/apps.who.int\/medicinedocs\/documents\/s16102e\/s16102e.pdf."},{"issue":"9693","key":"10.1016\/j.vaccine.2020.04.001_b0105","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet (London, England)"},{"issue":"9693","key":"10.1016\/j.vaccine.2020.04.001_b0110","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(09)61203-4","article-title":"Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates","volume":"374","author":"Watt","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2020.04.001_b0115","doi-asserted-by":"crossref","unstructured":"Siegrist C-A. Vaccine immunology. In: Stanley A. Plotkin WAO, Paul A. Offit. Vaccines (Sixth Edition) Vol. 2: W.B. Saunders, 2013:14-32.","DOI":"10.1016\/B978-1-4557-0090-5.00004-5"},{"issue":"31","key":"10.1016\/j.vaccine.2020.04.001_b0120","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1016\/j.vaccine.2016.04.066","article-title":"Pertussis vaccination during pregnancy in Belgium: follow-up of infants until 1 month after the fourth infant pertussis vaccination at 15 months of age","volume":"34","author":"Maertens","year":"2016","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20304588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:54Z","timestamp":1759401834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20304588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":24,"journal-issue":{"issue":"29","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0264410X20304588"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infant antibody levels following 10-valent pneumococcal-protein D conjugate and DTaP-Hib vaccinations in the first year of life after maternal Tdap vaccination: An open-label, parallel, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}